Proteomic Characterization of Primary Human Pancreatic Cancer Cell Lines Following Long-Term Exposure to Gemcitabine
Abstract
Share and Cite
Amrutkar, M.; Li, Y.; Finstadsveen, A.V.; Verbeke, C.S.; Gladhaug, I.P. Proteomic Characterization of Primary Human Pancreatic Cancer Cell Lines Following Long-Term Exposure to Gemcitabine. Proteomes 2025, 13, 48. https://doi.org/10.3390/proteomes13040048
Amrutkar M, Li Y, Finstadsveen AV, Verbeke CS, Gladhaug IP. Proteomic Characterization of Primary Human Pancreatic Cancer Cell Lines Following Long-Term Exposure to Gemcitabine. Proteomes. 2025; 13(4):48. https://doi.org/10.3390/proteomes13040048
Chicago/Turabian StyleAmrutkar, Manoj, Yuchuan Li, Anette Vefferstad Finstadsveen, Caroline S. Verbeke, and Ivar P. Gladhaug. 2025. "Proteomic Characterization of Primary Human Pancreatic Cancer Cell Lines Following Long-Term Exposure to Gemcitabine" Proteomes 13, no. 4: 48. https://doi.org/10.3390/proteomes13040048
APA StyleAmrutkar, M., Li, Y., Finstadsveen, A. V., Verbeke, C. S., & Gladhaug, I. P. (2025). Proteomic Characterization of Primary Human Pancreatic Cancer Cell Lines Following Long-Term Exposure to Gemcitabine. Proteomes, 13(4), 48. https://doi.org/10.3390/proteomes13040048